PMCTPharmaCountry
    홈

규제 업데이트

FDA, EMA, TGA 및 글로벌 규제 동향

#ANDA080256 ×

UPDATED
규제 업데이트
2026년 8월 30일•1분 읽기
FDA Approves Lilly Methyltestosterone Tablet ANDA080256 (Discontinued)
FDA approved Lilly's ANDA080256 for methyltestosterone tablets (10 mg and 25 mg) buccal/sublingual on Dec 22 1971; both products are now discontinued.